Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-02

Clinical Trial Update: Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluated the efficacy of an anthocyanin mouthrinse for orthodontic-related oral inflammation, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anthocyanin Mouthrinse (Anthocyanin)

Snippet

Sponsor: Khon Kaen University | Conditions: Inflammation of Mouth, Acute Mucous Inflammation | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-08-02